195 related articles for article (PubMed ID: 36251745)
61. Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.
Monaghan SA; Dai L; Mapara MY; Normolle DP; Gollin SM; Lentzsch S
Leuk Lymphoma; 2013 Sep; 54(9):1965-74. PubMed ID: 23216269
[TBL] [Abstract][Full Text] [Related]
62. Genetics and cytogenetics of multiple myeloma: a workshop report.
Fonseca R; Barlogie B; Bataille R; Bastard C; Bergsagel PL; Chesi M; Davies FE; Drach J; Greipp PR; Kirsch IR; Kuehl WM; Hernandez JM; Minvielle S; Pilarski LM; Shaughnessy JD; Stewart AK; Avet-Loiseau H
Cancer Res; 2004 Feb; 64(4):1546-58. PubMed ID: 14989251
[TBL] [Abstract][Full Text] [Related]
63. Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.
Junxun L; Junru L; Meilan C; Chujia L; Shaoqian C; Jieyu Z; Zhuangjian Y; Fan Z; Juan O; Jing C; Juan L
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26166219
[TBL] [Abstract][Full Text] [Related]
64. Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia.
Jo I; Chung NG; Lee S; Kwon A; Kim J; Choi H; Jang W; Kim S; Lee JW; Yoon JH; Cho B; Han K; Kim Y; Kim M
Clin Chim Acta; 2019 Jan; 488():81-89. PubMed ID: 30389459
[TBL] [Abstract][Full Text] [Related]
65. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
66. Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma.
Szczepański T; van 't Veer MB; Wolvers-Tettero IL; Langerak AW; van Dongen JJ
Blood; 2000 Aug; 96(3):1087-93. PubMed ID: 10910926
[TBL] [Abstract][Full Text] [Related]
67. Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.
Fries C; Adlowitz DG; Spence JM; Spence JP; Rock PJ; Burack WR
Pediatr Blood Cancer; 2020 Jun; 67(6):e28280. PubMed ID: 32277801
[TBL] [Abstract][Full Text] [Related]
68. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
Dyer MJ; Akasaka T; Capasso M; Dusanjh P; Lee YF; Karran EL; Nagel I; Vater I; Cario G; Siebert R
Blood; 2010 Feb; 115(8):1490-9. PubMed ID: 20042721
[TBL] [Abstract][Full Text] [Related]
69. The Dawn of next generation DNA sequencing in myelodysplastic syndromes- experience from Pakistan.
Anwar N; Memon FA; Shahid S; Shakeel M; Irfan M; Arshad A; Naz A; Ujjan ID; Shamsi T
BMC Genomics; 2021 Dec; 22(1):903. PubMed ID: 34915860
[TBL] [Abstract][Full Text] [Related]
70. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; von dem Borne AE; van der Schoot CE
Blood; 1993 Jul; 82(2):581-9. PubMed ID: 8329713
[TBL] [Abstract][Full Text] [Related]
71. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
[TBL] [Abstract][Full Text] [Related]
72. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
Steenbergen EJ; Verhagen OJ; Nibbering CP; van den Berg H; van Leeuwen EF; Behrendt H; von dem Borne AE; van der Schoot CE
Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
[TBL] [Abstract][Full Text] [Related]
73. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin.
Beishuizen A; Hählen K; Hagemeijer A; Verhoeven MA; Hooijkaas H; Adriaansen HJ; Wolvers-Tettero IL; van Wering ER; van Dongen JJ
Leukemia; 1991 Aug; 5(8):657-67. PubMed ID: 1909409
[TBL] [Abstract][Full Text] [Related]
74. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
Szczepek AJ; Bergsagel PL; Axelsson L; Brown CB; Belch AR; Pilarski LM
Blood; 1997 Mar; 89(5):1824-33. PubMed ID: 9057669
[TBL] [Abstract][Full Text] [Related]
75. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
76. Isolated del(14)(q21) in a case of precursor B-cell acute lymphoblastic leukemia.
Meloni-Ehrig AM; Tirado CA; Chen K; Jahn J; Suchan S; Scheerle J; Crosby MG; Meany H; Seibel N; Leitenberg D; Heritage DW; Mowrey PN
Cancer Genet Cytogenet; 2005 Aug; 161(1):82-5. PubMed ID: 16080963
[TBL] [Abstract][Full Text] [Related]
77. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
[TBL] [Abstract][Full Text] [Related]
78. Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing.
Kim M; Jeon K; Hutt K; Zlotnicki AM; Kim HJ; Lee J; Kim HS; Kang HJ; Lee YK
PLoS One; 2021; 16(6):e0253541. PubMed ID: 34166440
[TBL] [Abstract][Full Text] [Related]
79. Detailed clonality analysis of relapsing precursor B acute lymphoblastic leukemia: implications for minimal residual disease detection.
Li AH; Rosenquist R; Forestier E; Lindh J; Roos G
Leuk Res; 2001 Dec; 25(12):1033-45. PubMed ID: 11684274
[TBL] [Abstract][Full Text] [Related]
80. KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.
Choi SM; Andea AA; Wang M; Behdad A; Shao L; Zhang Y; Lu X; Dittmann D; Castro J; Chen YH; Gao J
Diagn Pathol; 2018 Oct; 13(1):78. PubMed ID: 30322385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
